Logo
en
en
Background pattern

Medicines with Tetanus toxoid in Spain

Filters
B

Boostrix polio suspension inyectable en jeringa precargada

Dosage form: Suspension for injection in pre‑filled syringe, 8 μg/8 μg/2.5 μg/40 U.D. (UNITS OF ANTIGEN D)/8 U.D. (UNITS OF ANTIGEN D)/32 U.D. (UNITS OF ANTIGEN D)/2.5 Lf/5 Lf
Active substance: Filamentous hemagglutinin of Bordetella pertussis, Bordetella pertussis pertactin, Bordetella pertussis toxoid, Diphtheria toxoid, Tetanus toxoid, Poliovirus type I, Poliovirus type II, Poliovirus type III
Manufacturer: Glaxosmithkline S.A.
Prescription required

Boostrix suspension inyectable en jeringa precargada

Dosage form: Suspension for injection in pre‑filled syringe, 2 units IU/2.5 µg/8 µg/8 µg/20 units IU
Active substance: Filamentous hemagglutinin of Bordetella pertussis, Bordetella pertussis 69 kDa outer-membrane protein, Bordetella pertussis toxoid, Diphtheria toxoid, Tetanus toxoid
Manufacturer: Glaxosmithkline S.A.
Prescription required
H

Hexyon suspension inyectable en jeringa precargada

Dosage form: Suspension for injection, 20 UI/40 UI/25 µg/25 µg/40 U.D. (UNITS OF ANTIGENIC D)/8 U.D. (UNITS OF ANTIGENIC D)/32 U.D. (UNITS OF ANTIGENIC D)/10 µg/12 µg
Active substance: Hepatitis B surface antigen, Filamentous hemagglutinin of Bordetella pertussis, Bordetella pertussis toxoid, Inactivated poliovirus type 1 (Mahoney) produced in Vero cells, Inactivated poliovirus type 2 (MEF-1) produced in Vero cells, Inactivated poliovirus type 3 (Saukett) produced in Vero cells, Capsular polysaccharide Haemophilus influenzae type b (PRP), Diphtheria toxoid, Tetanus toxoid
Manufacturer: Sanofi Winthrop Industrie
Prescription required

Hexyon suspension inyectable en jeringa precargada

Dosage form: Suspension for injection in pre‑filled syringe, 40 Units/25 µg/25 µg/40 U.D. (UNITS OF ANTIGEN D)/8 U.D. (UNITS OF ANTIGEN D)/32 U.D. (UNITS OF ANTIGEN D)/10 µg/12 µg/20 Units
Active substance: Hepatitis B surface antigen, Filamentous hemagglutinin of Bordetella pertussis, Bordetella pertussis toxoid, Haemophilus influenzae type b polysaccharide conjugated to tetanus toxoid, Inactivated poliovirus type 1 (Mahoney) produced in Vero cells, Inactivated poliovirus type 2 (MEF-1) produced in Vero cells, Inactivated poliovirus type 3 (Saukett) produced in Vero cells, Diphtheria toxoid, Tetanus toxoid
Manufacturer: Sanofi Winthrop Industrie
Prescription required
I

Infanrix hexa polvo y suspension para suspension inyectable

Dosage form: Powder and solvent for suspension for injection, 30 UI/40 UI/0.02 mg/0.01 mg/0.025 mg/0.025 mg/0.01 mg/40 U.D. (UNITS OF ANTIGENIC D)/8 U.D. (UNITS OF ANTIGENIC D)/32 U.D. (UNITS OF ANTIGENIC D)/0.01 mg
Active substance: Hepatitis B surface antigen, Filamentous hemagglutinin of Bordetella pertussis, Bordetella pertussis 69 kDa outer-membrane protein, Bordetella pertussis toxoid, Haemophilus influenzae type b polysaccharide conjugated to tetanus toxoid, Haemophilus influenzae type B, Diphtheria toxoid, Tetanus toxoid, Poliovirus type I, Poliovirus type II, Poliovirus type III
Manufacturer: Glaxosmithkline Biologicals
Prescription required

Infanrix hexa polvo y suspension para suspension inyectable

Dosage form: Powder and solvent for suspension for injection, 30 UI/40 UI/20 µg/10 µg/25 µg/25 µg/10 µg/40 UNITS OF ANTIGEN D)/8 UNITS OF ANTIGEN D)/32 UNITS OF ANTIGEN D)/10 µg
Active substance: Hepatitis B surface antigen, Filamentous hemagglutinin of Bordetella pertussis, Bordetella pertussis 69 kDa outer-membrane protein, Bordetella pertussis toxoid, Haemophilus influenzae type b polysaccharide conjugated to tetanus toxoid, Haemophilus influenzae type B, Diphtheria toxoid, Tetanus toxoid, Poliovirus type I, Poliovirus type II, Poliovirus type III
Manufacturer: Glaxosmithkline Biologicals
Prescription required

Infanrix-ipv suspension inyectable en jeringa precargada

Dosage form: Suspension for injection in pre‑filled syringe, 30 UI/40 UI/25 µg/25 µg/8 µg/40 UNITS/D/8 UNITS/D/32 UNITS/D
Active substance: Filamentous hemagglutinin of Bordetella pertussis, Bordetella pertussis pertactin, Bordetella pertussis toxoid, Inactivated poliovirus type 1 (Mahoney) produced in Vero cells, Inactivated poliovirus type 2 (MEF-1) produced in Vero cells, Inactivated poliovirus type 3 (Saukett) produced in Vero cells, Diphtheria toxoid, Tetanus toxoid
Manufacturer: Glaxosmithkline S.A.
Prescription required
M

Menquadfi solucion inyectable

Dosage form: Solution for injection, 10 micrograms/mL/10 micrograms/mL/10 micrograms/mL/10 micrograms/mL/55 micrograms/mL
Active substance: Meningococcal polysaccharide antigen group W-135, Meningococcal polysaccharide antigen group Y, Meningococcal polysaccharide antigen group A, Meningococcal polysaccharide antigen group C., Tetanus toxoid
Manufacturer: Sanofi Winthrop Industrie
Prescription required

Menquadfi soluciÓn inyectable

Dosage form: Solution for injection, 10 µg/10 µg/10 µg/10 µg/55 µg
Active substance: Meningococcal polysaccharide antigen group W-135, Meningococcal polysaccharide antigen group Y, Meningococcal polysaccharide antigen group A, Meningococcal polysaccharide antigen group C., Tetanus toxoid
Manufacturer: Sanofi Winthrop Industrie
Prescription required
T

Tetraxim suspension inyectable en jeringa precargada

Dosage form: Suspension for injection in pre‑filled syringe, 20 UI/40 UI/25 µg/25 µg/40 U.D. (ANTIGENIC UNITS)/8 U.D. (ANTIGENIC UNITS)/32 U.D. (ANTIGENIC UNITS)
Active substance: Filamentous hemagglutinin of Bordetella pertussis, Bordetella pertussis toxoid, Inactivated poliovirus type 1 (Mahoney) produced in Vero cells, Inactivated poliovirus type 2 (MEF-1) produced in Vero cells, Inactivated poliovirus type 3 (Saukett) produced in Vero cells, Diphtheria toxoid, Tetanus toxoid
Manufacturer: Sanofi Winthrop Industrie
Prescription required

Triaxis suspension inyectable en jeringa precargada

Dosage form: Suspension for injection in pre‑filled syringe, 2 UI/20 UI/2.5 µg/5 µg/3 µg/5 µg
Active substance: Pertussis toxoid fimbriae agglutinin, Filamentous hemagglutinin of Bordetella pertussis, Bordetella pertussis pertactin, Bordetella pertussis toxoid, Diphtheria toxoid, Tetanus toxoid
Manufacturer: Sanofi Winthrop Industrie
Prescription required
V

Vaxelis suspension inyectable en jeringa precargada

Dosage form: Suspension for injection in pre‑filled syringe, Greater than or equal to 20 IU/Greater than or equal to 40 IU/20 µg/20 µg/3 µg/5 µg/40 U.D. (UNITS OF ANTIGENIC D)/8 U.D. (UNITS OF ANTIGENIC D)/32 U.D. (UNITS OF ANTIGENIC D)/10 µg/3 µg
Active substance: Pertussis toxoid fimbriae agglutinin, Hepatitis B surface antigen, Filamentous hemagglutinin of Bordetella pertussis, Bordetella pertussis pertactin, Bordetella pertussis toxoid, Conjugated Haemophilus influenzae type b (Hib) PRP-N. Meningococcus OMP-C, Inactivated poliovirus type 1 (Mahoney) produced in Vero cells, Inactivated poliovirus type 2 (MEF-1) produced in Vero cells, Inactivated poliovirus type 3 (Saukett) produced in Vero cells, Diphtheria toxoid, Tetanus toxoid
Manufacturer: Mcm Vaccine B.V.
Prescription required

Get updates and exclusive offers

Be the first to know about new services, platform updates, and subscriber-only promos.

Follow us on social media
FacebookInstagramTikTok
ServicesDoctorsHelp
Search